Page 67 - 16Neonatal Jaundice_compressed

Neonatal jaundice

(including economic modelling) from the evidence used to form recommendations were also
prepared. In areas where no substantial evidence was identified, the GDG considered other
evidence-based guidelines and consensus statements or used their collective experience to
identify good practice. The GDG also identified areas where evidence to answer their clinical
questions was lacking and used this information to draft recommendations for future research.
Towards the end of the guideline development process, formal consensus methods were used to
consider all the clinical care recommendations that had been drafted previously. Consensus was
again used to agree the wording of recommendations. All recommendations for which at least
one GDG member indicated any level of disagreement were discussed at a subsequent GDG
meeting, and the final wording was agreed following discussion of the relevant issues.
The GDG identified key priorities for implementation which were those recommendations
expected to have the biggest impact on patients’ care and patients’ outcomes in the NHS as a
whole. Each GDG member submitted a paper form indicating their top ten recommendations in
order of priority. The GDG members’ votes were collated and priority recommendations were
obtained by including all recommendations that had been voted for by at least four GDG
members in order of popularity.
Stakeholder involvement in the guideline development process

Registered stakeholder organisations were invited to comment on the draft scope of the
guideline and on the draft guideline. Stakeholder organisations were also invited to undertake a
pre-publication check of the final guideline to identify factual inaccuracies. The GDG carefully
considered and responded to all comments received from stakeholder organisations. The
comments and responses, which were reviewed independently for NICE by a Guidelines
Review Panel, are published on the NICE website.

40